| Stage | ARDT | % of rev | CVLG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.6B | 100.00% | $234M | 100.00% | ARDT ×6.93 |
| Gross profit | $946M | 58.32% | $86M | 36.80% | ARDT +21.5pp |
| Operating income | $43M | 2.66% | $9M | 3.78% | CVLG +1.1pp |
| Pre-tax income | $43M | 2.66% | $11M | 4.75% | CVLG +2.1pp |
| Net income | $35M | 2.14% | $9M | 3.65% | CVLG +1.5pp |
| Stage | ARDT | CVLG | Gap · A − B |
|---|---|---|---|
| Revenue | $1.6B100.00% | $234M100.00% | ARDT ×6.93 |
| Gross profit | 58.32%$946M | 36.80%$86M | ARDT +21.5pp |
| Operating income | 2.66%$43M | 3.78%$9M | CVLG +1.1pp |
| Pre-tax income | 2.66%$43M | 4.75%$11M | CVLG +2.1pp |
| Net income |
| 2.14%$35M |
| 3.65%$9M |
| CVLG +1.5pp |
None
No disclosed counterparties: ARDT.